Researchers hailing from Houston have uncovered a remarkable characteristic of the widely used medication “Candesartan,” typically prescribed for individuals suffering from hypertension. It turns out this drug is highly effective at eradicating Staphylococcus aureus (MRSA)—one of the most perilous infections known for its resistance to antibiotics. The findings from this investigation have been featured in the journal Nature Communications.
The mechanism through which the drug operates is truly distinctive: it essentially perforates the bacterial cell membrane, causing the cell’s internal contents to leak out. Experiments demonstrated that the medication manages to eliminate even the “dormant” variants of the infection, those that can conceal themselves within the body for years, leading to recurrent issues. Furthermore, when administered alongside standard antibiotics, its potency is dramatically magnified.
The primary advantage of this discovery lies in its established safety profile. Considering that this medication has been in medical use for decades and is economically accessible, scientists will bypass the lengthy process of assessing its toxicity. Currently, the research team is actively seeking collaborators to expedite the initiation of human clinical trials, a development that could represent a significant leap forward in combating hospital-acquired infections.
About the Author
